Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_assertion description "[However, oncogenic transforming PIK3CA mutations have been shown to predict a better outcome in ER+/HER2-negative BC treated with endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_assertion evidence source_evidence_literature NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_assertion SIO_000772 24011769 NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_assertion wasDerivedFrom befree-2016 NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_assertion wasGeneratedBy ECO_0000203 NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1108206.RAcMxpuI0wSfB0GbPTZPw_qhwguWYL1mEVQvQ6-Xpgdp8130_provenance.